Publications (151) Luis Chiva de Agustín publications

filter_list

2024

  1. Accuracy of pre-operative tumor size assessment compared to final pathology and frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical cancer

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, Vol. 34, Núm. 12, pp. 1861-1866

  2. An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial)

    International Journal of Gynecological Cancer, Vol. 34, Núm. 6, pp. 942-945

  3. Assessing minimally invasive simple hysterectomy in low risk cervical cancer: Set up for the LASH trial

    International Journal of Gynecological Cancer, Vol. 34, Núm. 11, pp. 1805-1808

  4. Best original research presented at the 25th European Congress on Gynaecological Oncology: Best of ESGO 2024

    International Journal of Gynecological Cancer, Vol. 34, Núm. 9, pp. 1324-1333

  5. Cardiophrenic lymph node dissection in ovarian cancer patients

    Ovarian Cancer: The "Gynaecological Challenge? From Diagnostic Work-Up to Cytoreduction and Chemotherapy (Nova Science Publishers, Inc.), pp. 155-160

  6. ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 35, Núm. 3, pp. 248-266

  7. Endovascular management of hypervascular retained products of conception: A comprehensive review

    Radiologia

  8. High pre-Delta and early-Omicron SARS-CoV-2 seroprevalence detected in dried blood samples from Kinshasa (D.R. Congo)

    Journal of Medical Virology, Vol. 96, Núm. 3

  9. Management challenges in low-grade serous ovarian cancer with a BRCA mutation

    International Journal of Gynecological Cancer, Vol. 34, Núm. 4, pp. 631-636

  10. Maternal and Fetal Outcomes after Multiple Cesarean Deliveries

    Journal of Clinical Medicine, Vol. 13, Núm. 15

  11. Ovarian cancer during fertility follow-up

    International Journal of Gynecological Cancer, Vol. 34, Núm. 9, pp. 1479-1480

  12. Primary and secondary postpartum haemorrhage: a review for a rationale endovascular approach

    CVIR ENDOVASCULAR, Vol. 7, Núm. 1

  13. Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma

    Journal of Personalized Medicine, Vol. 14, Núm. 2

  14. Response to: Correspondence on ‘An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial)’ by Chiva et al.

    International Journal of Gynecological Cancer

  15. SENECA study: staging endometrial cancer based on molecular classification

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, Vol. 34, Núm. 9, pp. 1313-1321

  16. SUCCOR morbidity: Complications in minimally invasive versus open radical hysterectomy in early cervical cancer

    International Journal of Gynecological Cancer, Vol. 34, Núm. 2, pp. 203-208

  17. Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer

    Bulletin du Cancer, Vol. 111, Núm. 3, pp. 277-284

  18. Surgical anatomy - essential knowledge for ovarian debulking

    Ovarian Cancer: The "Gynaecological Challenge? From Diagnostic Work-Up to Cytoreduction and Chemotherapy (Nova Science Publishers, Inc.), pp. 1-33

  19. The art of bowel surgery in gynecologic cancer

    International Journal of Gynecological Cancer, Vol. 34, Núm. 3, pp. 421-425